International Journal of Clinical Pediatric Dentistry

Register      Login

VOLUME 16 , ISSUE S3 ( November, 2023 ) > List of Articles

CASE REPORT

Nonsurgical Management of Drug-induced Gingival Overgrowth in a Young Patient

Keywords : Antiepileptic drug, Gingival overgrowth, Phenytoin

Citation Information :

DOI: 10.5005/jp-journals-10005-2482

License: CC BY-NC 4.0

Published Online: 11-01-2024

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Background: Gingival enlargement or gingival overgrowth (GO) is a very common complication of the various classes of drugs and the most common being, the anticonvulsant drug phenytoin (PHT). PHT and its metabolites have a direct effect on the periodontal tissues; with poor oral hygiene also contributing to the severity of inflammation in patients with drug-induced gingival overgrowth (DIGO). Case description: Here we present a case of PHT-induced gingival overgrowth (PGO) in a 12-year-old male patient and discuss the management of the condition. Conclusion: Management of drug-induced overgrowth of gingiva includes strict oral hygiene maintenance practice, meticulous professional care with several adjunctive periodontal therapies like photodynamic therapy and Local drug delivery. Surgical treatment is indicated if the overgrown tissue has become fibrotic. Clinical significance: The pediatric dentist plays an important role in early identification and proper management of the condition by timely intervention and collaboration with other specialists.


HTML PDF Share
  1. Wentz LA, Oliveira SC, Moreira CH, et al. Low prevalence of gingival overgrowth associated to new immunosuppressive protocols with cyclosporin. Braz Oral Res 2012;26(1):64–70. DOI: 10.1590/s1806-83242011005000016
  2. Greenberg KV, Armitage GC, Shiboski CH. Gingival enlargement among renal transplant recipients in the era of new-generation immunosuppressants. J Periodontol 2008;79(3):453–460. DOI: 10.1902/jop.2008.070434
  3. James JA, Boomer S, Maxwell AP, et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol 2000;27(2):144–148. DOI: 10.1034/j.1600-051x.2000.027002144.x
  4. Doufexi A, Mina M, Ioannidou E. Gingival overgrowth in children: Epidemiology, pathogenesis, and complications. A literature review. J Periodontol 2005;76(1):3–10. DOI: 10.1902/jop.2005.76.1.3
  5. Dhale RP, Phadnaik MB. Conservative management of amlodipine influenced gingival enlargement. J Indian Soc Periodontol 2009;13(1):41–43. DOI: 10.4103/0972-124X.51894
  6. Lu HK, Tseng CC, Lee YH, et al. Flutamide inhibits nifedipine- and interleukin-1 beta-induced collagen overproduction in gingival fibroblasts. J Periodontal Res 2010;45(4):451–457. DOI: 10.1111/j.1600-0765.2009.01255.x
  7. Kim JY, Park SH, Cho KS, et al. Mechanism of azithromycin treatment on gingival overgrowth. J Dent Res 2008;87(11):1075–1079. DOI: 10.1177/154405910808701110
  8. Agrawal AA. Gingival enlargements: differential diagnosis and review of literature. World J Clin Cases 2015;3(9):779–788. DOI: 10.12998/wjcc.v3.i9.779
  9. Bader HI. Adjunctive periodontal therapy: a review of current techniques. Dent Today 2010;29(7):94–96.
  10. Sume SS, Kantarci A, Lee A, et al. Epithelial to mesenchymal transition in gingival overgrowth. Am J Pathol 2010;177(1):208–218. DOI: 10.2353/ajpath.2010.090952
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.